Protagenic Therapeutics Inc. (PTIX)

[Slyder75]

http://www.cov.com/files/Publication/011e84d9-2fc6-47ff-9e18-004e7e65ba81/Presentation/PublicationAttachment/b51363ab-5a85-49fb-b486-040799fbf1d1/769.pdf

Page 13 of this document, second paragraph, right hand column. You got it wrong...

Unlike deregistration under Rule 12d2-2, there
is no lapse in time between the fi ling of a Form 15
under Rule 12g-4 and the suspension of an issuer’s
obligation to fi le periodic reports under Section
13(a) of the Exchange Act. Once a Form 15 is
fi led, assuming an issuer does not have a reporting
obligation under Section 15(d), an issuer’s obligation
to fi le periodic reports with the Commission
under Section 13(a) is suspended immediately. As
with Form 25, however, an issuer remains registered
under Section 12(g) of the Exchange Act,
and thus subject to the remaining provisions of the
Exchange Act, including the proxy rules, Section
16 and certain provisions of the Williams Act, until
the expiration of 90 days from the date on which
the Form 15 is fi led.8